Wearable non-invasive neuromodulation device for the symptomatic treatment of the voice disorder spasmodic dysphonia

Arash Mahnan, Jürgen Konczak, Sayed Abdolrasoul Faraji

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Scopus citations

Abstract

Spasmodic dysphonia (SD) is a voice disorder that leads to strained or choked speech. SD is unresponsive to speech therapy. There is no cure for SD. Preliminary work from our group showed that voice quality in SD improves when vibro-tactile stimulation (VTS) is applied over the larynx as a non-invasive form of neuromodulation. The goal of this paper is to describe the design and development of a non-invasive wearable device, which applies VTS to laryngeal muscles with the aim to improve voice quality of individuals with SD. This paper provides preliminary data about the effectiveness of this wearable device for treating the voice symptoms associated with SD.

Original languageEnglish (US)
Title of host publicationFrontiers in Biomedical Devices, BIOMED - 2019 Design of Medical Devices Conference, DMD 2019
PublisherAmerican Society of Mechanical Engineers (ASME)
ISBN (Electronic)9780791841037
DOIs
StatePublished - 2019
Event2019 Design of Medical Devices Conference, DMD 2019 - Minneapolis, United States
Duration: Apr 15 2019Apr 18 2019

Publication series

NameFrontiers in Biomedical Devices, BIOMED - 2019 Design of Medical Devices Conference, DMD 2019

Conference

Conference2019 Design of Medical Devices Conference, DMD 2019
CountryUnited States
CityMinneapolis
Period4/15/194/18/19

Bibliographical note

Funding Information:
Previous and ongoing support for this project through the University of Minnesota's Clinical and Translational Science Institute (CTSI) and NIH 1 R21 DC014315 to Juergen Konczak.

Publisher Copyright:
Copyright © 2019 ASME

Keywords

  • Dysphonia
  • Medical device
  • Neurorehabilitation
  • Vibro-tactile stimulation

Fingerprint Dive into the research topics of 'Wearable non-invasive neuromodulation device for the symptomatic treatment of the voice disorder spasmodic dysphonia'. Together they form a unique fingerprint.

Cite this